CAMK2G and neoplasm: The treatment with KN-93, the specific CaMKII inhibitor, significantly attenuated the OPN-CMs increased cell survivals from the 5-FU administration (Fig. 4).The results also implied for tumor progression linked to the activation of calcium signal pathways and the activity of CaMK needed to be considered.